Gartisertib T10407
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ATR inhibitor 2 is an orally active, ATP-competitive, and selective ATR inhibitor (Ki <150 pM) with antitumor activity. ATR inhibitor 2 potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation (IC50: 8 nM).
CAS nr:
1613191-99-3
Purity:
98%
Molecular Weight:
541,55
SMILES:
O=C(C1=C2N=CC(F)=CN2N=C1N)NC3=C(N4CCC(C(N5CCN(C6COC6)CC5)=O)CC4)C(F)=CN=C3
Formula:
C25H29F2N9O3
Pathway:
DNA Damage/DNA Repair,PI3K/Akt/mTOR signaling
Target:
ATM/ATR,ATM/ATR
